Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin

Detalhes bibliográficos
Autor(a) principal: Potor, László
Data de Publicação: 2013
Outros Autores: Bányai, Emese, Becs, Gergely, Soares, Miguel P., Balla, György, Balla, József, Jeney, Viktória
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.7/474
Resumo: Oxidized cell-free hemoglobin (Hb), including covalently cross-linked Hb multimers, is present in advanced atherosclerotic lesions. Oxidation of Hb produces methemoglobin (Fe(3+)) and ferryl hemoglobin (Fe(4+) = O(2-)). Ferryl iron is unstable and can return to the Fe(3+) state by reacting with specific amino acids of the globin chains. In these reactions globin radicals are produced followed by termination reactions yielding covalently cross-linked Hb multimers. Despite the evanescent nature of the ferryl state, herein we refer to this oxidized Hb as "ferryl Hb." Our aim in this work was to study formation and biological effects of ferrylHb. We demonstrate that ferrylHb, like metHb, can release its heme group, leading to sensitization of endothelial cells (ECs) to oxidant-mediated killing and to oxidation of low-density lipoprotein (LDL). Furthermore, we observed that both oxidized LDL and lipids derived from human atherosclerotic lesions trigger Hb oxidation and subsequent production of covalently cross-linked ferrylHb multimers. Previously we showed that ferrylHb disrupts EC monolayer integrity and induces expression of inflammatory cell adhesion molecules. Here we show that when exposed to ferrylHb, EC monolayers exhibit increased permeability and enhanced monocyte adhesion. Taken together, interactions between cell-free Hb and atheroma lipids engage in a vicious cycle, amplifying oxidation of plaque lipids and Hb. These processes trigger EC activation and cytotoxicity.
id RCAP_11ee66008c3c722c109d7b6c990b79a8
oai_identifier_str oai:arca.igc.gulbenkian.pt:10400.7/474
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl HemoglobinAtherosclerosisInflammation MediatorsFerritinsHemoglobinsOxidized cell-free hemoglobin (Hb), including covalently cross-linked Hb multimers, is present in advanced atherosclerotic lesions. Oxidation of Hb produces methemoglobin (Fe(3+)) and ferryl hemoglobin (Fe(4+) = O(2-)). Ferryl iron is unstable and can return to the Fe(3+) state by reacting with specific amino acids of the globin chains. In these reactions globin radicals are produced followed by termination reactions yielding covalently cross-linked Hb multimers. Despite the evanescent nature of the ferryl state, herein we refer to this oxidized Hb as "ferryl Hb." Our aim in this work was to study formation and biological effects of ferrylHb. We demonstrate that ferrylHb, like metHb, can release its heme group, leading to sensitization of endothelial cells (ECs) to oxidant-mediated killing and to oxidation of low-density lipoprotein (LDL). Furthermore, we observed that both oxidized LDL and lipids derived from human atherosclerotic lesions trigger Hb oxidation and subsequent production of covalently cross-linked ferrylHb multimers. Previously we showed that ferrylHb disrupts EC monolayer integrity and induces expression of inflammatory cell adhesion molecules. Here we show that when exposed to ferrylHb, EC monolayers exhibit increased permeability and enhanced monocyte adhesion. Taken together, interactions between cell-free Hb and atheroma lipids engage in a vicious cycle, amplifying oxidation of plaque lipids and Hb. These processes trigger EC activation and cytotoxicity.Hungarian Academy of Sciences, Hungarian Government Grants: (OTKA-K75883, OTKAK83478, OTKA- PD83435), European Union and the European Social Fund: (T´AMOP-4.2.2.A-11/1/KONV-2012-0045 and T´AMOP-4.2.2/B-10/1-2010-0024).Hindawi Publishing CorporationARCAPotor, LászlóBányai, EmeseBecs, GergelySoares, Miguel P.Balla, GyörgyBalla, JózsefJeney, Viktória2015-11-06T17:04:13Z2013-04-232013-04-23T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.7/474engLászló Potor, Emese Bányai, Gergely Becs, et al., “Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 676425, 13 pages, 2013. doi:10.1155/2013/67642510.1155/2013/676425info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-11-29T14:34:51Zoai:arca.igc.gulbenkian.pt:10400.7/474Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:11:45.004508Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
title Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
spellingShingle Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
Potor, László
Atherosclerosis
Inflammation Mediators
Ferritins
Hemoglobins
title_short Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
title_full Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
title_fullStr Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
title_full_unstemmed Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
title_sort Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
author Potor, László
author_facet Potor, László
Bányai, Emese
Becs, Gergely
Soares, Miguel P.
Balla, György
Balla, József
Jeney, Viktória
author_role author
author2 Bányai, Emese
Becs, Gergely
Soares, Miguel P.
Balla, György
Balla, József
Jeney, Viktória
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv ARCA
dc.contributor.author.fl_str_mv Potor, László
Bányai, Emese
Becs, Gergely
Soares, Miguel P.
Balla, György
Balla, József
Jeney, Viktória
dc.subject.por.fl_str_mv Atherosclerosis
Inflammation Mediators
Ferritins
Hemoglobins
topic Atherosclerosis
Inflammation Mediators
Ferritins
Hemoglobins
description Oxidized cell-free hemoglobin (Hb), including covalently cross-linked Hb multimers, is present in advanced atherosclerotic lesions. Oxidation of Hb produces methemoglobin (Fe(3+)) and ferryl hemoglobin (Fe(4+) = O(2-)). Ferryl iron is unstable and can return to the Fe(3+) state by reacting with specific amino acids of the globin chains. In these reactions globin radicals are produced followed by termination reactions yielding covalently cross-linked Hb multimers. Despite the evanescent nature of the ferryl state, herein we refer to this oxidized Hb as "ferryl Hb." Our aim in this work was to study formation and biological effects of ferrylHb. We demonstrate that ferrylHb, like metHb, can release its heme group, leading to sensitization of endothelial cells (ECs) to oxidant-mediated killing and to oxidation of low-density lipoprotein (LDL). Furthermore, we observed that both oxidized LDL and lipids derived from human atherosclerotic lesions trigger Hb oxidation and subsequent production of covalently cross-linked ferrylHb multimers. Previously we showed that ferrylHb disrupts EC monolayer integrity and induces expression of inflammatory cell adhesion molecules. Here we show that when exposed to ferrylHb, EC monolayers exhibit increased permeability and enhanced monocyte adhesion. Taken together, interactions between cell-free Hb and atheroma lipids engage in a vicious cycle, amplifying oxidation of plaque lipids and Hb. These processes trigger EC activation and cytotoxicity.
publishDate 2013
dc.date.none.fl_str_mv 2013-04-23
2013-04-23T00:00:00Z
2015-11-06T17:04:13Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.7/474
url http://hdl.handle.net/10400.7/474
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv László Potor, Emese Bányai, Gergely Becs, et al., “Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 676425, 13 pages, 2013. doi:10.1155/2013/676425
10.1155/2013/676425
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hindawi Publishing Corporation
publisher.none.fl_str_mv Hindawi Publishing Corporation
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130572955582464